How do I buy Medpace Holdings, Inc. (MEDP) stock?

Buying Medpace Holdings, Inc. (MEDP) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and verify your identity. Make a deposit. Search for the code "MEDP", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy MEDP by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

What is the minimum investment for MEDP on Gotrade?

On Gotrade , you don't have to buy a full share. With fractional shares, you can start investing in Medpace Holdings, Inc. from just $1. A small budget shouldn't stop you from building a US stock portfolio.

Does Medpace Holdings, Inc. (MEDP) pay dividends?

At the moment, Medpace Holdings, Inc. (MEDP) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track MEDP's performance via the price chart in the Gotrade app.

Is buying MEDP on Gotrade safe and legal?

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

What are the market hours to buy MEDP?

You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too. The market is closed on US public holidays. The Gotrade app shows whether the market is open.

How do I tell if MEDP is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Medpace Holdings, Inc. (MEDP) Stock Price: Nov 11 Close $664.77

Latest news

Zacks Investment Research

News tone: automated (AI) classification of the article's content, not a price prediction.

About Medpace Holdings, Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

SectorHealthcare

IndustryDiagnostics & Research

Employees6,500

CEODr. August James Troendle M.D.

IPO DateAug 11, 2016

HeadquartersCincinnati, OH

Key Executives

Name	Title	Year Born
Dr. August James Troendle M.D.	CEO, President & Chairman	1956
Mr. Stephen P. Ewald J.D.	Chief Compliance Officer, General Counsel & Corporate Secretary	1969
Mr. Brad W. Hansman	Executive Vice President of Operations	1983

Fundamentals

Valuation

Price-to-sales ratio8.33

Price-to-book value31.78

PEG ratio3.27

Profitability

Return on Equity110.00%

Return on Assets25.00%

Return on Sales21.00%

Gross margin (latest quarter)31.27%

EBITDA$637.17M

Trading

Average volume323,059

Source: third-party data provider, as of November 13, 2026

Technical indicators

RSI 14: 55.86
MACD 12/26/9: 10.70
EMA 9 of MACD: 11.93
MACD histogram: -1.24
SMA 50: $627.03; Price above SMA 50
EMA 50: $630.14; Price above EMA 50
SMA 200: $531.41; Price above SMA 200
EMA 200: $564.30; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.

Analyst views

6 analyst ratings

Third-party analyst opinion, not a recommendation from Gotrade.

Analyst consensus:Hold

17% Buy

83% Hold

0% Sell

Analyst price target

Low: $633.00
Average: $675.17
High: $700.00

Barclays

Luke Sergott

Hold

Target price

$675.00

Mizuho

Ann Hynes

Buy

Target price

$700.00

TD Cowen

Charles Rhyee

Hold

Target price

$673.00

UBS

Kevin Caliendo

Hold

Target price

$700.00

BMO Capital

Sean Dodge

Hold

Target price

$670.00

Truist Securities

Jailendra Singh

Hold

Target price

$633.00

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											-5.2	+4.1
2022	-17.2	-13.1	+7.7	-20.5	+4.0	+4.7	+13.3	-12.0	+6.5	+38.0	-5.6	-1.5
2023	+6.1	-14.8	-4.2	+5.3	+0.2	+16.1	+5.9	+5.7	-11.5	+0.0	+7.6	+11.3
2024	-4.6	+34.7	-0.0	-2.4	-2.9	+5.8	+8.8
2026		+2.2	+5.0	-14.5	+7.1	+17.3	+6.2	+3.6	+7.0	+9.0	+2.6

Compare stocks

MEDP

Buy MEDP

Market cap

$18.59B

-

Price / Earnings ratio

35.90

-

Price / Sales ratio

8.33

-

Dividend yield

0.00%

-

Average volume

323,059

-

Earnings per share

$18.34

-

Medpace Holdings, Inc. (MEDP) Stock

Key stats

Compare with MEDP

Recent news

CON vs. MEDP: Which Stock Is the Better Value Option?

CON vs. MEDP: Which Stock Is the Better Value Option?

Medpace (MEDP) is a Great Momentum Stock: Should You Buy?

Medpace (MEDP) is a Great Momentum Stock: Should You Buy?

Medpace Holdings, Inc. (MEDP) Hits Fresh High: Is There Still Room to Run?

Medpace Holdings, Inc. (MEDP) Hits Fresh High: Is There Still Room to Run?

Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think "Yes"

Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think "Yes"

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

CON vs. MEDP: Which Stock Is the Better Value Option?

CON vs. MEDP: Which Stock Is the Better Value Option?

Medpace (MEDP) is a Great Momentum Stock: Should You Buy?

Medpace (MEDP) is a Great Momentum Stock: Should You Buy?

Medpace Holdings, Inc. (MEDP) Hits Fresh High: Is There Still Room to Run?

Medpace Holdings, Inc. (MEDP) Hits Fresh High: Is There Still Room to Run?

Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think "Yes"

Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think "Yes"

All You Need to Know About Medpace (MEDP) Rating Upgrade to Buy

All You Need to Know About Medpace (MEDP) Rating Upgrade to Buy

Here's Why Medpace (MEDP) is a Strong Growth Stock

Here's Why Medpace (MEDP) is a Strong Growth Stock

Medpace: 3 Key Takeaways for Long-Term Investors

Medpace: 3 Key Takeaways for Long-Term Investors

Medpace Q3 Earnings Call Highlights

Medpace Q3 Earnings Call Highlights

Medpace (MEDP) Q3 Earnings and Revenues Beat Estimates

Medpace (MEDP) Q3 Earnings and Revenues Beat Estimates

Medpace Slips Despite Third-Quarter Beat, Solid Earnings Outlook

Medpace Slips Despite Third-Quarter Beat, Solid Earnings Outlook

About Medpace Holdings, Inc.

Key Executives

Fundamentals

Valuation

Profitability

Trading

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade